NEW YORK, March 8, 2018 /PRNewswire/ -- Milberg Tadler Phillips Grossman LLP, an investor protection firm, has commenced an investigation of Denver, Colorado-based BioScrip, Inc. (BIOS) regarding possible violations of federal securities laws. On March 8, 2018, BioScrip announced in its release of fourth quarter and full year financial results an ongoing internal accounting review after identifying "internal control deficiencies in connection with account reconciliations for certain asset and liability accounts." Further, the Company disclosed that it "has identified and will report a material weakness related to certain spreadsheets used to calculate periodic adjustments to" accounts.
In reaction to the news, BioScrip shares fell 15%, closing at $2.6 per share from $3.07 per share the previous day, on much higher volume than normal. For additional information please contact:
Andrei Rado, Esq.
Milberg Tadler Phillips Grossman LLP
One Pennsylvania Plaza, 19th Fl.
New York, NY 10119
Phone number: 800-320-5081
Milberg Tadler Phillips Grossman LLP is an investor and consumer protection firm.
Attorney Advertising. Prior results do not guarantee a similar outcome.
SOURCE Milberg Tadler Phillips Grossman LLP